Skip to main content

Advertisement

Correction to: Management of adult-onset Still’s disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts

  • 100 Accesses

The original article was published in Arthritis Research & Therapy 2019 21:275

Correction to: Arthritis Res Ther (2019) 21:275

https://doi.org/10.1186/s13075-019-2021-9

Following publication of the original article [1], it was brought to our attention that the AOSD Consensus Group was incorrectly tagged and therefore not searchable. The publishers apologize for this error.

Reference

  1. 1.

    Colafrancesco S, et al. Management of adult-onset Still’s disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts. Arthritis Res Ther. 2019;21:275. https://doi.org/10.1186/s13075-019-2021-9.

Download references

Acknowledgements

Experts who contributed to the project by participating in the Delphi process.

Stefano Alivernini, Institute of Rheumatology and Affine Sciences, Division of Rheumatology, Catholic University of the Sacred Heart, Rome.

Elena Baldissera, Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute, Milan.

Elena Bartoloni, Rheumatology Unit, Department of Medicine, University of Perugia, Perugia.

Alvise Berti, Department of Rheumatology, Santa Chiara Hospital, University of Trento, Trento.

Serena Bugatti, Department of Rheumatology, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia.

Dario Camellino, Division of Rheumatology, La Colletta Hospital, Arenzano.

Daniele Cammelli, Department of Experimental and Clinical Medicine, University of Florence, Florence.

Roberto Caporali, Department of Rheumatology, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia.

Francesco Caso, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples.

Elena Cavallaro, Department of Medical and Biological Sciences, Rheumatology Clinic, University of Udine, Udine.

Giulio Cavalli, Department of Internal Medicine, Vita-Salute San Raffaele University, Milan.

Michele Colaci, Department of Clinical and Experimental Medicine, Internal Medicine Unit, Cannizzaro Hospital, University of Catania, Catania.

Luisa Costa, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples.

Gerardo di Scala, Rheumatology Section/Immunoallergology Unit, AOU Careggi, Florence.

Giacomo Emmi, Rheumatology Section/Immunoallergology Unit, AOU Careggi, Florence.

Micol Frassi, Rheumatology and Clinical Immunology, Spedali Civili and Department of Clinical and Experimental Sciences, University of Brescia, Brescia.

Roberto Gerli, Rheumatology Unit, Department of Medicine, University of Perugia, Perugia.

Roberto Giacomelli, Department of Biotechnological and Applied Clinical Science, Division of Rheumatology, University of L’Aquila, L’Aquila.

Elisa Gremese, Institute of Rheumatology and Affine Sciences, Division of Rheumatology, Catholic University of the Sacred Heart, Rome.

Florenzo Iannone, Rheumatology Unit, Interdisciplinary Department of Medicine, University of Bari, Bari.

Giovanni Lapadula, Rheumatology Unit, Interdisciplinary Department of Medicine, University of Bari, Bari.

Lorenzo Leveghi, Department of Rheumatology, Santa Chiara Hospital, University of Trento, Trento.

Andrea Lo Monaco, Rheumatology Unit, Department of Clinical and Experimental Medicine, Sant’Anna Hospital, University of Ferrara, Ferrara.

Giuseppe Lopalco, Rheumatology Unit, Interdisciplinary Department of Medicine, University of Bari, Bari.

Raffaele Manna, Periodic Fever Research Center, Institute of Internal Medicine, Catholic University of the Sacred Heart, Fondazione Policlinico A. Gemelli, Rome.

Daniela Marotto, Rheumatology, Department of Medical Sciences and Public Health, Assl Olbia, Olbia.

Alessandro Mathieu, Rheumatology Unit, Department of Medical Sciences, University and AOU of Cagliari, Cagliari.

Rossella Neri, Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa.

Isabella Patisso, Periodic Fever Research Center, Institute of Internal Medicine, Catholic University of the Sacred Heart, Fondazione Policlinico A. Gemelli, Rome.

Matteo Piga, Rheumatology Unit, Department of Medical Sciences, University and AOU of Cagliari, Cagliari.

Leonardo Punzi, Rheumatology Unit, Department of Medicine - DIMED, University of Padova, Padova.

Micol Romano, Division of Rheumatology, ASST Gaetano Pini, Milan.

Piero Ruscitti, Department of Biotechnological and Applied Clinical Science, Division of Rheumatology, University of L’Aquila, L’Aquila.

Carlo Salvarani, Rheumatology Unit, Azienda USL-IRCCS di Reggio Emilia and University of Modena e Reggio Emilia.

Raffaele Scarpa, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples.

Rossana Scrivo, Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome.

Rosaria Talarico, Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa.

Elena Verrecchia, Periodic Fever Research Center, Institute of Internal Medicine, Catholic University of the Sacred Heart, Fondazione Policlinico A. Gemelli, Rome.

Ombretta Viapiana, Rheumatology Unit, Department of Medicine, University of Verona, Verona.

Antonio Vitale, Research Center of Systemic Autoinflammatory Diseases and Behçet’s Disease, Clinic Surgery and Neurosciences, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena.

Gianfranco Vitiello, Department of Experimental and Clinical Medicine, University of Florence, Florence.

Author information

Correspondence to Serena Colafrancesco.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Colafrancesco, S., Manara, M., Bortoluzzi, A. et al. Correction to: Management of adult-onset Still’s disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts. Arthritis Res Ther 22, 6 (2020) doi:10.1186/s13075-019-2094-5

Download citation